Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2026.03.09

High-Throughput Experimentation platform goes live in Hyderabad

The High Throughput Experimentation (HTE) platform is now operational at our Integrated R&D Campus in Hyderabad, India. The system integrates automated experimental execution with structured data capture to support reproducible, high-quality screening and full traceability of results.

Designed to evaluate multiple variables within a single experimental matrix, the platform enables rapid assessment of chemical space during route scouting, optimization, and troubleshooting activities. This supports data-driven route selection and reduces uncertainty prior to scale-up.

Reactions are conducted at microscale, minimizing material consumption while enabling broad condition screening. The capability extends beyond catalytic chemistry and includes diverse reaction classes such as biocatalysis, with further expansion planned.

HTE is particularly effective for screening categorical variables and selecting reagents in a structured and data-driven manner. Screening outputs are generated with downstream process development in mind, ensuring translation into scalable workflows rather than remaining isolated exploratory data.

The platform is intended to accelerate decision-making, improve experimental consistency, and enhance confidence in process development strategies across programs.

Share article

More News

2026.03.09

New Medicinal Chemistry block set for inauguration in Hyderabad

A new Medicinal Chemistry block, Unit VIII, is set for inauguration at IKP, Genome Valley, Hyderabad, expanding discovery capacity to meet growing program demand. The four-floor facility spans approximately 100,000 sq. ft. and is designed to support large, multi-disciplinary project teams. It accommodates more than 200 fume hoods and includes a tightly integrated analytical laboratory […]
Read more

2026.03.09

AI-enabled production and material planning platform implemented

Over the past several months, focused AI pilot initiatives have been conducted across operations to evaluate practical applications that strengthen execution. One such initiative is now live across the network: Optimus, an integrated AI-enabled production and material planning platform, implemented at the end of December 2025. Optimus consolidates capacity planning, equipment allocation, and material availability […]
Read more

2026.03.09

Commercial-scale Photo Flow Chemistry successfully executed in Bidar

Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a US-based innovator. This execution builds on prior investments in continuous processing infrastructure at the site, including a 3-litre photo flow reactor equipped with a monochromatic blue LED light source. The platform enables controlled photochemical transformations […]
Read more

2026.02.20

Sai Life Sciences to recruit 700+ professionals in FY27

Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India’s leading integrated contract research, development and manufacturing organizations (CRDMOs), today announced plans to hire 700+ scientific, technical, and management professionals during 2026–27 as it scales capabilities to meet growing global demand for end-to-end drug discovery, development and manufacturing services.The recruitment will span roles […]
Read more

2026.02.06

Sai Life Sciences Limited delivers robust performance in 9MFY26

Revenue up by 43%; EBITDA up by 79%; Net Profit up by 199% Hyderabad, February 05, 2026: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO) announced its financial results for the third quarter and nine months ended December 2025. Financial Performance: Particulars […]
Read more